Lifecore Biomedical Inc
NASDAQ:LFCR
Lifecore Biomedical Inc
Non-Reccuring Items
Lifecore Biomedical Inc
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
Non-Reccuring Items
-$6.3m
|
CAGR 3-Years
51%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Hershey Co
NYSE:HSY
|
Non-Reccuring Items
-$20.6m
|
CAGR 3-Years
53%
|
CAGR 5-Years
34%
|
CAGR 10-Years
27%
|
|
|
General Mills Inc
NYSE:GIS
|
Non-Reccuring Items
$854.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kellogg Co
NYSE:K
|
Non-Reccuring Items
-$44m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
18%
|
|
|
Kraft Heinz Co
NASDAQ:KHC
|
Non-Reccuring Items
-$9.4B
|
CAGR 3-Years
-98%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Mondelez International Inc
NASDAQ:MDLZ
|
Non-Reccuring Items
-$106m
|
CAGR 3-Years
37%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
What is Lifecore Biomedical Inc's Non-Reccuring Items?
Non-Reccuring Items
-6.3m
USD
Based on the financial report for Sep 30, 2025, Lifecore Biomedical Inc's Non-Reccuring Items amounts to -6.3m USD.
What is Lifecore Biomedical Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
22%
Over the last year, the Non-Reccuring Items growth was -10%. The average annual Non-Reccuring Items growth rates for Lifecore Biomedical Inc have been 51% over the past three years , 22% over the past five years .
